Status:
ACTIVE_NOT_RECRUITING
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
Lead Sponsor:
University of California, San Francisco
Conditions:
Corona Virus Infection
COVID
Eligibility:
FEMALE
18+ years
Brief Summary
Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development throug...
Detailed Description
ASPIRE is focused on the first trimester, a critical and vulnerable period when all of a baby's organ systems form and the placenta - the crucial connection between mom and baby - develops. Currently...
Eligibility Criteria
Inclusion
- Over age 18
- Participant is 4-10 weeks pregnant (gestation)
Exclusion
- \- Male (biologically unable to achieve pregnancy)
Key Trial Info
Start Date :
April 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
7965 Patients enrolled
Trial Details
Trial ID
NCT04388605
Start Date
April 21 2020
End Date
December 1 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158